24 de febrero de 2021
In
Michal Wlodarski
Michal Wlodarski
Chief Executive Officer
Solvemed Group
United Kingdom
Master of Pharmacy (MPharm) degree from the UCL School of Pharmacy and trained as a clinical and industrial pharmacist at the NHS England and GlaxoSmithKline R&D
PhD degree in Biological Sciences from the University of Cambridge
INTERVENCIONES
26/03/2021
12:15 - 13:15